Pharmaceuticals in North America
Summary
Pharmaceuticals in North America industry profile provides topline qualitative and quantitative summary information including: market share, market size value 201317, and forecast to 2022. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for topline data and analysis covering the North America pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The North American pharmaceuticals market had total revenues of $444.3bn in 2017, representing a compound annual growth rate CAGR of 7.6% between 2013 and 2017.
Obesity is an increasingly bigger problem in North America which means a large demand for medication for its comorbidities heart disease and diabetes.
The US is by far the largest market in the region, and maintains good growth consistently despite its developed nature due to the very strong private health sector.
Scope
Save time carrying out entrylevel research by identifying the size, growth, and leading players in the pharmaceuticals market in North America
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts
Reasons to buy
What was the size of the North America pharmaceuticals market by value in 2017?
What will be the size of the North America pharmaceuticals market in 2022?
What factors are affecting the strength of competition in the North America pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in North America's pharmaceuticals market?